Keywords: kosan, initiates, phase, ii, usa-based, biosciences, initiated

Kosan initiates Phase II

Article | 21 February 2005

USA-based Kosan Biosciences has initiated a multi-center Phase II clinical trial of its candidate prostate cancer therapy KOS-862 (epothilone D). ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing